Jeffrey Matous, MD

Financial relationships

  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Janssen Pharmacyclic's
    Topic:
    Advisory board
    Date added:
    05/01/2023
    Date updated:
    05/01/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    BeiGene
    Topic:
    Advisory Board
    Date added:
    05/01/2023
    Date updated:
    05/01/2023
    Relationship end date:
    12/31/2023
Return to 13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego